<p>Stevanato Group Spa（STVN）召开了第三季度财报电话会议。请继续阅读会议的主要亮点。</p>
<h3>认识您的 ETF AI 分析师</h3>
<ul>
<li>了解 TipRanks 的 ETF AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong>ETF AI 分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
<p>Stevanato Group Spa 最近的财报电话会议传达了整体积极的情绪，强劲的收入增长和利润率扩张是会议的亮点。尽管公司在工程部门面临挑战以及外汇影响，但通过战略投资和令人称道的 ESG 表现，展现了韧性。</p>
<h2>创纪录的收入增长</h2>
<p>Stevanato Group 报告第三季度收入同比增长 9%，主要得益于生物药物解决方案（BDS）部门 14% 的激增。这一增长主要是由于核心药物包装业务需求的增加，展示了公司强大的市场地位。</p>
<h2>高价值解决方案的强劲表现</h2>
<p>公司的高价值解决方案部门经历了显著的 47% 增长，占公司总收入的 49%。这一增长是由于对 Nexa 注射器和 EZ-fill 小瓶需求的增加，突显了公司对高价值产品的战略关注。</p>
<h2>利润率扩张</h2>
<p>Stevanato Group 实现了显著的利润率扩张，合并毛利率提高了 240 个基点，达到了 29.2%。此外，调整后的 EBITDA 利润率提高了 280 个基点，达到了 25.7%，反映了公司的运营效率和成本管理。</p>
<h2>成功的资本投资</h2>
<p>公司在 Fishers 和 Latina 工厂的产能扩张方面取得了显著进展。这些投资将支持未来的增长，与公司的长期战略目标相一致。</p>
<h2>EcoVadis 银奖</h2>
<p>Stevanato Group 获得了 EcoVadis 银奖，位列全球评估公司中的前 15%。这一荣誉认可了公司在环境、社会和治理（ESG）实践方面的强劲表现。</p>
<h2>工程部门收入下降</h2>
<p>工程部门的收入下降了 19%，毛利率降至 10.4%。这归因于收入下降和复杂遗留项目比例增加，突显了公司面临的一个关键问题。</p>
<h2>外汇带来的逆风</h2>
<p>外汇转换带来了挑战，影响了收入增长约 1500 万至 1600 万美元。这一外部因素仍然是公司面临的重要逆风。</p>
<h2>工程部门复苏延迟</h2>
<p>工程部门在将管道机会转化为新订单方面仍然困难重重，导致财务表现低于预期。这一复苏延迟是未来关注的关键领域。</p>
<h2>前瞻性指导</h2>
<p>尽管面临挑战，Stevanato Group 维持了 2025 财年的指导，预计收入在 11.6 亿至 11.9 亿美元之间。公司预计调整后的 EBITDA 在 2.885 亿至 3.018 亿美元之间，调整后的稀释每股收益为 0.50 至 0.54 美元。持续的产能扩张，特别是在 Fishers 和 Latina 设施，预计将促进未来增长并满足对药物包装产品日益增长的需求。</p>
<p>总之，Stevanato Group 的财报电话会议反映了积极的前景，强劲的收入增长和利润率扩张。尽管工程部门和外汇影响面临挑战，但公司的战略投资和 ESG 表现值得称道。前瞻性指导依然乐观，继续关注高价值解决方案和产能扩张以推动未来增长。</p>

STVN

<p>Stevanato Group Spa (STVN) 报告了强劲的第三季度业绩，强调收入同比增长 9%，主要得益于生物药物解决方案部门 14% 的增长。高价值解决方案部门增长了 47%，对总收入贡献显著。公司实现了利润率扩张，毛利率上升至 29.2%。然而，工程部门的收入下降了 19%。尽管面临挑战，Stevanato 仍然维持其 2025 财年的指导预期，预计收入将在 11.6 亿美元至 11.9 亿美元之间，这得益于持续的产能扩张和对高价值产品的关注</p>

<p>Stevanato Group Spa ((STVN)) has held its Q3 earnings call. Read on for the main highlights of the call.</p>
<div class="lb-trans"><p>Stevanato Group Spa（STVN）召开了第三季度财报电话会议。请继续阅读会议的主要亮点。</p>
</div><h3>Meet Your ETF AI Analyst</h3>
<div class="lb-trans"><h3>认识您的 ETF AI 分析师</h3>
</div><ul>
<li>Discover how TipRanks' <em>ETF</em> AI Analyst can help you make smarter investment decisions</li>
<li>Explore ETFs TipRanks' users love and see what insights the <strong><em>ETF</em> AI Analyst</strong> reveals about the ones you follow.</li>
</ul>
<div class="lb-trans"><ul>
<li>了解 TipRanks 的 ETF AI 分析师如何帮助您做出更明智的投资决策</li>
<li>探索 TipRanks 用户喜爱的 ETF，并查看 <strong>ETF AI 分析师</strong> 对您关注的 ETF 所揭示的见解。</li>
</ul>
</div><p>The latest earnings call from Stevanato Group Spa conveyed a positive sentiment overall, with strong revenue growth and margin expansion being the highlights. The company has shown resilience through strategic investments and a commendable ESG performance, although it faces challenges in its Engineering segment and foreign currency impacts.</p>
<div class="lb-trans"><p>Stevanato Group Spa 最近的财报电话会议传达了整体积极的情绪，强劲的收入增长和利润率扩张是会议的亮点。尽管公司在工程部门面临挑战以及外汇影响，但通过战略投资和令人称道的 ESG 表现，展现了韧性。</p>
</div><h2>Record Revenue Growth</h2>
<div class="lb-trans"><h2>创纪录的收入增长</h2>
</div><p>Stevanato Group reported a 9% year-over-year increase in third-quarter revenue, largely driven by a 14% surge in the Biologics Drug Solutions (BDS) segment. This growth was primarily fueled by heightened demand in the core drug containment business, showcasing the company’s robust market position.</p>
<div class="lb-trans"><p>Stevanato Group 报告第三季度收入同比增长 9%，主要得益于生物药物解决方案（BDS）部门 14% 的激增。这一增长主要是由于核心药物包装业务需求的增加，展示了公司强大的市场地位。</p>
</div><h2>Strong Performance in High-Value Solutions</h2>
<div class="lb-trans"><h2>高价值解决方案的强劲表现</h2>
</div><p>The company’s high-value solutions segment experienced a remarkable 47% growth, contributing to 49% of the total company revenue. This was driven by the increasing demand for Nexa syringes and EZ-fill vials, underscoring the company’s strategic focus on high-value offerings.</p>
<div class="lb-trans"><p>公司的高价值解决方案部门经历了显著的 47% 增长，占公司总收入的 49%。这一增长是由于对 Nexa 注射器和 EZ-fill 小瓶需求的增加，突显了公司对高价值产品的战略关注。</p>
</div><h2>Margin Expansion</h2>
<div class="lb-trans"><h2>利润率扩张</h2>
</div><p>Stevanato Group achieved a significant margin expansion, with the consolidated gross profit margin increasing by 240 basis points to 29.2%. Additionally, the adjusted EBITDA margin improved by 280 basis points to 25.7%, reflecting the company’s operational efficiency and cost management.</p>
<div class="lb-trans"><p>Stevanato Group 实现了显著的利润率扩张，合并毛利率提高了 240 个基点，达到了 29.2%。此外，调整后的 EBITDA 利润率提高了 280 个基点，达到了 25.7%，反映了公司的运营效率和成本管理。</p>
</div><h2>Successful Capital Investments</h2>
<div class="lb-trans"><h2>成功的资本投资</h2>
</div><p>The company made notable progress in its capacity expansion efforts at the Fishers and Latina sites. These investments are set to support future growth, aligning with the company’s long-term strategic goals.</p>
<div class="lb-trans"><p>公司在 Fishers 和 Latina 工厂的产能扩张方面取得了显著进展。这些投资将支持未来的增长，与公司的长期战略目标相一致。</p>
</div><h2>EcoVadis Silver Medal</h2>
<div class="lb-trans"><h2>EcoVadis 银奖</h2>
</div><p>Stevanato Group was awarded the EcoVadis silver medal, placing it in the top 15% of companies assessed globally. This accolade recognizes the company’s strong performance in environmental, social, and governance (ESG) practices.</p>
<div class="lb-trans"><p>Stevanato Group 获得了 EcoVadis 银奖，位列全球评估公司中的前 15%。这一荣誉认可了公司在环境、社会和治理（ESG）实践方面的强劲表现。</p>
</div><h2>Decline in Engineering Segment</h2>
<div class="lb-trans"><h2>工程部门收入下降</h2>
</div><p>The Engineering segment faced a 19% decline in revenue, with its gross profit margin dropping to 10.4%. This was attributed to lower revenue and a higher proportion of complex legacy projects, highlighting a key area of concern for the company.</p>
<div class="lb-trans"><p>工程部门的收入下降了 19%，毛利率降至 10.4%。这归因于收入下降和复杂遗留项目比例增加，突显了公司面临的一个关键问题。</p>
</div><h2>Headwinds from Foreign Currency</h2>
<div class="lb-trans"><h2>外汇带来的逆风</h2>
</div><p>Foreign currency translation posed a challenge, impacting revenue growth by approximately $15 million to $16 million. This external factor remains a significant headwind for the company.</p>
<div class="lb-trans"><p>外汇转换带来了挑战，影响了收入增长约 1500 万至 1600 万美元。这一外部因素仍然是公司面临的重要逆风。</p>
</div><h2>Delayed Recovery in Engineering Segment</h2>
<div class="lb-trans"><h2>工程部门复苏延迟</h2>
</div><p>The Engineering segment continues to struggle with converting pipeline opportunities into new orders, resulting in financial performance that remains below expectations. This delayed recovery is a critical area for future focus.</p>
<div class="lb-trans"><p>工程部门在将管道机会转化为新订单方面仍然困难重重，导致财务表现低于预期。这一复苏延迟是未来关注的关键领域。</p>
</div><h2>Forward-Looking Guidance</h2>
<div class="lb-trans"><h2>前瞻性指导</h2>
</div><p>Despite the challenges, Stevanato Group maintained its fiscal 2025 guidance, expecting revenue between $1.16 billion and $1.19 billion. The company anticipates adjusted EBITDA between $288.5 million and $301.8 million, and adjusted diluted EPS of $0.50 to $0.54. The ongoing capacity expansion, particularly in the Fishers and Latina facilities, is expected to bolster future growth and meet rising demand for drug containment products.</p>
<div class="lb-trans"><p>尽管面临挑战，Stevanato Group 维持了 2025 财年的指导，预计收入在 11.6 亿至 11.9 亿美元之间。公司预计调整后的 EBITDA 在 2.885 亿至 3.018 亿美元之间，调整后的稀释每股收益为 0.50 至 0.54 美元。持续的产能扩张，特别是在 Fishers 和 Latina 设施，预计将促进未来增长并满足对药物包装产品日益增长的需求。</p>
</div><p>In summary, Stevanato Group’s earnings call reflected a positive outlook with strong revenue growth and margin expansion. While challenges persist in the Engineering segment and from foreign currency impacts, the company’s strategic investments and ESG performance are commendable. The forward-looking guidance remains optimistic, with continued focus on high-value solutions and capacity expansion to drive future growth.</p>
<div class="lb-trans"><p>总之，Stevanato Group 的财报电话会议反映了积极的前景，强劲的收入增长和利润率扩张。尽管工程部门和外汇影响面临挑战，但公司的战略投资和 ESG 表现值得称道。前瞻性指导依然乐观，继续关注高价值解决方案和产能扩张以推动未来增长。</p>
</div>

Stevanato Group 的财报电话会议突显了其稳健的增长